Taiwan FDA registration dee91401004f5ac6cb97efb84d5f53b7
“GENOSS” MONALISA Hyaluronic Acid Dermal Filler with Lidocaine
TW: “紀諾思” 蒙娜麗莎玻尿酸(含利多卡因)
Taiwan·Risk Class 3·MD·Genoss Co., Ltd.·Registered Oct 17, 2022 – Oct 17, 2027ActiveRegistration details
- Analysis ID
- dee91401004f5ac6cb97efb84d5f53b7
- License Form
- Ministry of Health Medical Device Import No. 035938
- Customs Code
- DHA05603593805
Company information
- Manufacturer
- Genoss Co., Ltd.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- Taike Medical Technology Co.,Ltd
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I0007 Hyaluronic acid implants
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 17, 2022
- Expiry Date
- Oct 17, 2027
About this record
Access comprehensive regulatory information for “GENOSS” MONALISA Hyaluronic Acid Dermal Filler with Lidocaine in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number dee91401004f5ac6cb97efb84d5f53b7 and manufactured by Genoss Co., Ltd.. The authorized representative in Taiwan is Taike Medical Technology Co.,Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices